Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

Pfizer shares jump 4% after diabetes drug shows weight-loss results

Pfizer stock was up 4.2% on Monday after a study of its diabetes treatment danuglipron found that a high dose of the drug reduced body weight by more than...

Forget Ozempic injections — a pill version of the weight loss drug could be coming soon

Iryna Veklich, Getty Images A daily pill version of the medicine that's in the popular drug Ozempic could be coming soon. It's designed to promote weight loss in overweight and obese adults without a weekly shot. Results of a large trial suggest people achieved around 15% weight loss after about 1 year.  A once-daily pill version of the drug popularly known as Ozempic is one step closer to market.Drugmaker Novo Nordisk announced the results of a…

Pfizer Jumps After Journal Publishes Weight-Loss Pill Data

Pfizer Inc.’s experimental pill helped people with diabetes lose weight in published results from a short-term trial that were also presented at a conference in Europe last fall.

Novo Nordisk says trial of oral weight-loss drug shows significant result

COPENHAGEN -- Novo Nordisk said on Monday a late-stage trial of an oral version of its drug semaglutide for weight loss has shown statistically significant and superior weight loss when compared to a placebo.

Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic

Pfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal.